EP2392576

ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    7.7.2009
  • EP published:
    17.2.2016
  • EP application number:
    09793788.2
  • Max expiry date:
    6.7.2029
  • Title:
    ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF

Timeline

Today
7.7.2009EP application
17.2.2016EP Publication

Owner

  • Name:
    Beta Pharma, Inc.
  • Address:
    5 Vaughn Drive, Suite 106, 08540, Princeton, NJ, US

Inventor

  • Name:
    WANG, Yinxiang
  • Address:
    Beijing, CN
  • Name:
    DING, Lieming
  • Address:
    HangzhouZhejiang, CN
  • Name:
    TAN, Fenlai
  • Address:
    Beijing, CN
  • Name:
    HU, Yunyan
  • Address:
    Beijing, CN
  • Name:
    HE, Wei
  • Address:
    Beijing, CN
  • Name:
    HAN, Bin
  • Address:
    Beijing, CN
  • Name:
    LONG, Wei
  • Address:
    Beijing, CN
  • Name:
    LIU, Yong
  • Address:
    Beijing, CN
  • Name:
    AL, Haima
  • Address:
    Beijing, CN
  • Name:
    ZHANG, Don
  • Address:
    Branford, Connecticut, US
  • Name:
    DAVIS, Charles
  • Address:
    Branford, Connecticut, US
  • Name:
    XIE, Guojian
  • Address:
    Branford, Connecticut, US

Priority

  • Number:
    200810132631
  • Date:
    8.7.2008
  • Country:
    CN
  • Number:
    200810132458
  • Date:
    17.7.2008
  • Country:
    CN
  • Number:
    200810188272
  • Date:
    23.12.2008
  • Country:
    CN

Classification

  • Categories:
    C07D 491/056, A61K 31/519, A61P 35/00

Upload documents